No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
PFE240712C27500
- 0.38
- -0.18-32.14%
15min DelayClose Jul 9 16:00 ET
0.53High0.18Low
0.48Open0.56Pre Close3.07K Volume1.18K Open Interest27.50Strike Price90.06KTurnover27.34%IV0.58%PremiumJul 12, 2024Expiry Date0.22Intrinsic Value100Multiplier2DDays to Expiry0.16Extrinsic Value100Contract SizeAmericanOptions Type0.6434Delta0.5730Gamma71.08Leverage Ratio-0.0521Theta0.0013Rho45.73Eff Leverage0.0089Vega
Intraday
- 5D
- Daily
News
Express News | Pfizer : Barclays Raises Target Price to $30 From $28
Barclays Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $30
Barclays analyst Gena Wang maintains $Pfizer(PFE.US)$ with a hold rating, and adjusts the target price from $28 to $30.According to TipRanks data, the analyst has a success rate of 46.2% and a total
J.P. Morgan Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30
J.P. Morgan analyst Chris Schott maintains $Pfizer(PFE.US)$ with a hold rating, and maintains the target price at $30.According to TipRanks data, the analyst has a success rate of 50.2% and a total
Evotec, Pfizer Team Up for Early Drug Discovery for Metabolic, Infectious Diseases
Evotec (EVT.F) and pharmaceutical company Pfizer (PFE.F) entered into a multi-year master research collaboration and option and license agreement to conduct early discovery research for metabolic
Express News | Evotec SE Shares up 2.3% After Collaboration Agreement With Pfizer
J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)
Comments
$Pfizer(PFE.US$
According to Zhittong Finance, Pfizer announced on Tuesday that Mikael Dolsten, its Chief Scientific Officer and R&D President, will leave the company after more than 15 years of service. The New York-based pharmaceutical giant said it would launch a months-long external recruitment program to identify a new Chief Scientific Officer, a move expected to last until early next year. The company said, "Dolsten will assist in job search and continue in his current role until his s...
According to Zhittong Finance, Pfizer announced on Tuesday that Mikael Dolsten, its Chief Scientific Officer and R&D President, will leave the company after more than 15 years of service. The New York-based pharmaceutical giant said it would launch a months-long external recruitment program to identify a new Chief Scientific Officer, a move expected to last until early next year. The company said, "Dolsten will assist in job search and continue in his current role until his s...
2
2
Morning Movers
Gapping up
$Amazon(AMZN.US$ stock increased by 0.13% after the company unveiled a new $79 Echo Spot alarm clock featuring a refreshed design and enhanced audio quality.
$Intel(INTC.US$ stock leapt 2.68% following a previous session gain of over 6%, with Nvidia also up 1.57% and Marvell rising by 0.69%, as AI-associated stocks continued to gain favor.
$Pfizer(PFE.US$ stock inched up by 0.18% on the news that i...
Gapping up
$Amazon(AMZN.US$ stock increased by 0.13% after the company unveiled a new $79 Echo Spot alarm clock featuring a refreshed design and enhanced audio quality.
$Intel(INTC.US$ stock leapt 2.68% following a previous session gain of over 6%, with Nvidia also up 1.57% and Marvell rising by 0.69%, as AI-associated stocks continued to gain favor.
$Pfizer(PFE.US$ stock inched up by 0.18% on the news that i...
29
1
$Pfizer(PFE.US$ No one knows how long it'll take before the dragon awakes and takes off. Maybe years?
3
Read more
Sung Jun Lee : DJT was set nasdac short selling so not rise up.
may be July will rise up ,Biden will down ....
Sung Jun Lee : DJT is auto too much short selling nasdac.Biden out of presiden and set short selling finished and rise up.
Ultratech Sung Jun Lee: you like trump so much but you understand he creates a lot of market crashes. as an investor you do not want him unless shorting. the stock market hates uncertainty more than bad news. Trump brings a lot of uncertainty. youtube "trump lashes out at big tech"